Fast Pharma News Round-Up

Elon Musk unveils plan to build mind-reading implants

Neuralink, a secretive “brain-machine interface” start-up owned by Elon Musk, revealed that it has been working on creating a wireless implantable device that can, theoretically, read your mind. (Source: theguardian.com)

DRC rejects clinical trial for J&J experimental Ebola vaccine

The health minister for the Democratic Republic of Congo (DRC) has previously suggested that a Johnson & Johnson vaccine could have clinical trials in his country to help battle the Ebola outbreak however, this has now been rejected. (Source: europeanpharmaceuticalreview.com)

New statistics show decrease in animals used for R&D

The Home Office has released its annual statistics on animals used in research in Great Britain. It shows 3.52 million procedures were carried out in 2018, a 7% decrease on the 2017 numbers. (Source: pharmafield.co.uk)

Music ‘calms nerves before surgery’ as well as sedative

US researched are claiming that by listening to the “world’s most relaxing song” that patients’ nerves can be calmed just as effectively as when using a sedative. (Source: bbc.co.uk)

Success for GSK’s Zejula in ovarian cancer

GlaxoSmithKline has announced positive headline results from its Phase III PRIMA study of Zejula (niraparib) for patients with ovarian cancer in the first line maintenance setting.                        (Source: pharmatimes.com)